Skip to main content
SMS Pharmaceuticals Ltd logo

SMS Pharmaceuticals Ltd — Investor Relations & Filings

Ticker · SMSPHARMA ISIN · INE812G01025 LEI · 335800XXEADQCB7GJ514 BSE.NS Manufacturing
Open in API
Filings indexed 747 across all filing types
Latest filing 2021-05-21 Regulatory Filings
Country IN India
Listing BSE.NS SMSPHARMA

About SMS Pharmaceuticals Ltd

https://smspharma.com/

SMS Pharmaceuticals Ltd specializes in the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The organization operates multiple manufacturing units and research centers, maintaining compliance with international regulatory standards including USFDA approvals. Its core product portfolio covers therapeutic areas such as anti-ulcerants, anti-migraine agents, anti-hypertensives, and anti-retrovirals. Beyond its proprietary product line, the company provides Contract Research and Manufacturing Services (CRAMS), offering expertise in process development, chemical synthesis, and analytical validation. The company focuses on delivering high-quality chemical solutions through integrated research and development capabilities, supporting global supply chains with a commitment to technical excellence and operational efficiency.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings Classification · 90% confidence The document text is extremely short (74 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report title, regulatory references, or any indication of the document type. Given the lack of content, it cannot be classified as a report or detailed filing. According to the rules, such minimal content with no report details defaults to Regulatory Filings (RNS) as a fallback category.
2021-05-21 English
Updates
Regulatory Filings Classification · 100% confidence The document text is extremely short (132 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report title, no regulatory references, no announcements, or any textual information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2021-04-24 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2021-04-23 English
Trading Window
Regulatory Filings Classification · 100% confidence The document text contains only a placeholder for a picture and no substantive content or text. The true document length is only 54 characters, which is extremely short and does not contain any report, announcement, or detailed information. Given the lack of content, this document cannot be classified as any specific report or announcement type. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without substantive content.
2021-03-30 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the publication of financial results for the quarter and nine months ended 31st December 2020. It includes detailed financial data such as total income, profit before and after tax, comprehensive income, equity share capital, and earnings per share. The document mentions that these results have been reviewed by the Audit Committee and approved by the Board of Directors, and that a limited review by statutory auditors has been carried out. The document also references compliance with SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, and states that the full format of quarterly financial results is available on stock exchange websites. The presence of unaudited financial statements and the quarterly period indicate this is a quarterly financial report. The document is not merely an announcement of a report but contains substantive financial data and analysis for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2021-02-12 English
Outcome of Board Meeting
Regulatory Filings
2021-02-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.